Bret Jensen
Contributor since: 2010
Company: The Biotech Forum
BioDelivery's Bountiful Growth
Assessing Allena Pharmaceuticals
GlycoMimetics: Grinding Its Way Back
Supernus Pharmaceuticals: Solid Bet Into Year End
Reassessing Aerie Pharmaceuticals
Heron Therapeutics: Priming The Fuse
Assessing Aquestive Therapeutics
Sinking Sarepta
Stemline Therapeutics: Still A Believer
The Play On Coherus BioSciences
The Play On Intercept Pharmaceuticals
Editas Medicine: A Good Proxy For The Gene Editing Space
Flexion Therapeutics: Holding Its Own
Biohaven Pharmaceutical: An Intriguing CNS Play
Intra-Cellular Therapies: Revisiting The Investment Case
Theravance Biopharma: Gaining Traction
BioDelivery: Getting Close To Cash Flow Positive
Omeros: Moving Forward
Exelixis: Mid-Cap Oncology Concern Continues To Deliver Growth
Heron Therapeutics: Brighter Days Ahead
Checking In On Iterum Therapeutics
Revisiting Global Blood Therapeutics
Our Take On Minerva Neurosciences
Behind Gilead's Big Move On Galapagos
Eloxx Pharmaceuticals: Buy, Sell Or Hold?
Kicking The Tires On Merus
3 Small Biotech Stocks Insiders Are Buying
Assessing Aravive
Assessing An Investment In Matinas BioPharma
Intra-Cellular Therapies: Key Catalyst On The Horizon
Spring Bank: An Interesting $5 Biotech Concern
MacroGenics: Updating The Investment Thesis